About
Omnicyte is a preclinical stage biotechnology company developing targeted immuno-oncology therapies using a proprietary platform to address multiple cancers including ovarian cancer and lung cancer.
Explore Omnicyte's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.